[一般医院的类风湿性关节炎患者 - 在治疗前和治疗期间需要考虑什么?]
Melanie Kraus1,2, Kriemhild Lippay1
1Praxis Pfeffingen.
Praxis
|March 18, 2025
概括
瑞士的风湿性关节炎管理包括优化疾病修饰性抗风湿药物 (DMARD) 和解决感染风险. 早期查和预防对于风湿性关节炎 (RA) 患者至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 一般的做法一般的做法
背景情况:
- 风湿性关节炎 (RA) 是瑞士普遍存在的慢性炎症性自身免疫性疾病,影响着高达1%的人口.
- 关节炎患者经常咨询全科医生,需要全面的管理策略.
- 这种疾病及其治疗方法增加了感染易感性,需要主动查和预防.
研究的目的:
- 提供当前类风湿性关节炎 (RA) 治疗方案的概述.
- 概述RA患者的查和感染预防指南.
- 为了符合欧洲风湿病协会联盟 (EULAR) 和瑞士风湿病学会 (SGR) 的建议.
主要方法:
- 审查目前的类风湿性关节炎 (RA) 治疗指南.
- 对免疫功能低下患者的感染查和预防方案的分析.
- 综合了EULAR和SGR的建议.
主要成果:
- 第一线的RA治疗包括甲状腺和潜在的葡萄糖皮质类药物.
- 根据疾病活性,症状控制和副作用,选择额外的疾病修饰性抗风湿药物 (DMARD).
- 治疗前对感染的查和疫苗接种状态的检查是必不可少的.
结论:
- 优化RA治疗的目的是改善生活质量,预防骨破坏,减少心血管死亡率.
- 感染风险的积极管理是RA护理的关键组成部分.
- 遵守EULAR和SGR指南可确保RA患者的基于证据的实践.
相关概念视频
Autoimmune Disorders
366
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
366
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
288
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
288
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
123
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
123
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92


